{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.ai-analytics.org/drug-product/62332-224#drug","name":"DARIFENACIN","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"62332-224"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA207681"},{"@type":"PropertyValue","propertyID":"UNII","value":"CR02EYQ8GV"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"9f6952c8-e547-4f3e-a978-a88d6ea9dc10"}],"activeIngredient":"DARIFENACIN HYDROBROMIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET, EXTENDED RELEASE","manufacturer":{"@type":"Organization","name":"Alembic Pharmaceuticals Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.ai-analytics.org/drug-approval/ANDA207681","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f6952c8-e547-4f3e-a978-a88d6ea9dc10","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-224"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-09-27T13:19:26.862Z"}}